Celltrion (XKRX:068270) Total Stockholders Equity : ₩16,980,683 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Celltrion Total Stockholders Equity?

Celltrion's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩16,980,683 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Celltrion's Book Value per Share for the quarter that ended in Dec. 2023 was ₩81,904.88. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Celltrion's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.11.

Celltrion Total Stockholders Equity Historical Data

The historical data trend for Celltrion's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Total Stockholders Equity Chart

Celltrion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

2,760,109.36

3,307,677.05

3,917,237.79

4,139,360.00

16,980,683.41

Celltrion Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															4,139,360.00	4,146,239.34	4,256,027.29	4,334,763.47	16,980,683.41

Celltrion (XKRX:068270) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Celltrion's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(16980683.407	-	0)	/	207.322
	=	81,904.88

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Celltrion's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1783304.274	+	107115.929)	/	16980683.407
	=	0.11

Celltrion Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Celltrion's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Celltrion (XKRX:068270) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840

Website

http://www.celltrion.com

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines